Renal cell carcinoma recurrences and metastases in primary non-metastatic patients: a population-based study
Tóm tắt
Từ khóa
Tài liệu tham khảo
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136(5):E359–E386. doi: 10.1002/ijc.29210
Lyrdal D, Aldenborg F, Holmberg E, Peeker R, Lundstam S (2013) Kidney cancer in Sweden: a decrease in incidence and tumour stage, 1979–2001. Scand J Urol 47(4):302–310. doi: 10.3109/00365599.2012.732608
Ferlay J, Parkin DM, Steliarova-Foucher E (2010) Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 46(4):765–781. doi: 10.1016/j.ejca.2009.12.014
Znaor A, Lortet-Tieulent J, Laversanne M, Jemal A, Bray F (2015) International variations and trends in renal cell carcinoma incidence and mortality. Eur Urol 67(3):519–530. doi: 10.1016/j.eururo.2014.10.002
Gandaglia G, Ravi P, Abdollah F, Abd-El-Barr AE, Becker A, Popa I, Briganti A, Karakiewicz PI, Trinh QD, Jewett MA, Sun M (2014) Contemporary incidence and mortality rates of kidney cancer in the United States. Can Urol Assoc J 8(7–8):247–252. doi: 10.5489/cuaj.1760
Ljungberg B, Bensalah K, Canfield S, Dabestani S, Hofmann F, Hora M, Kuczyk MA, Lam T, Marconi L, Merseburger AS, Mulders P, Powles T, Staehler M, Volpe A, Bex A (2015) EAU guidelines on renal cell carcinoma: 2014 update. Eur Urol 67(5):913–924. doi: 10.1016/j.eururo.2015.01.005
Sun M, Thuret R, Abdollah F, Lughezzani G, Schmitges J, Tian Z, Shariat SF, Montorsi F, Patard JJ, Perrotte P, Karakiewicz PI (2011) Age-adjusted incidence, mortality, and survival rates of stage-specific renal cell carcinoma in North America: a trend analysis. Eur Urol 59(1):135–141. doi: 10.1016/j.eururo.2010.10.029
Bianchi M, Sun M, Jeldres C, Shariat SF, Trinh QD, Briganti A, Tian Z, Schmitges J, Graefen M, Perrotte P, Menon M, Montorsi F, Karakiewicz PI (2012) Distribution of metastatic sites in renal cell carcinoma: a population-based analysis. Ann Oncol 23(4):973–980. doi: 10.1093/annonc/mdr362
Flanigan RC, Mickisch G, Sylvester R, Tangen C, Van Poppel H, Crawford ED (2004) Cytoreductive nephrectomy in patients with metastatic renal cancer: a combined analysis. J Urol 171(3):1071–1076. doi: 10.1097/01.ju.0000110610.61545.ae
Dabestani S, Marconi L, Hofmann F, Stewart F, Lam TB, Canfield SE, Staehler M, Powles T, Ljungberg B, Bex A (2014) Local treatments for metastases of renal cell carcinoma: a systematic review. Lancet Oncol 15(12):e549–e561. doi: 10.1016/S1470-2045(14)70235-9
Socialstyrelsen (2003) Uppgiftsskyldighet till cancerregistret. Socialstyrelsens Författninssamling. https://www.socialstyrelsen.se/sosfs/2003-13 . Accessed 29 Oct 2015
Ludvigsson JF, Otterblad-Olausson P, Pettersson BU, Ekbom A (2009) The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research. Eur J Epidemiol 24(11):659–667. doi: 10.1007/s10654-009-9350-y
Guðmundsson E, Hellborg H, Lundstam S, Erikson S, Ljungberg B, Group SKCQR (2011) Metastatic potential in renal cell carcinomas ≤7 cm: Swedish kidney cancer quality register data. Eur Urol 60(5):975–982. doi: 10.1016/j.eururo.2011.06.029
Thorstenson A, Bergman M, Scherman-Plogell AH, Hosseinnia S, Ljungberg B, Adolfsson J, Lundstam S (2014) Tumour characteristics and surgical treatment of renal cell carcinoma in Sweden 2005–2010: a population-based study from the national Swedish kidney cancer register. Scand J Urol 48(3):231–238. doi: 10.3109/21681805.2013.864698
Thorstenson A, Harmenberg U, Lindblad P, Ljungberg B, Lundstam S, Swedish Kidney Cancer Quality Register G (2015) Impact of quality indicators on adherence to National and European guidelines for renal cell carcinoma. Scand J Urol. doi: 10.3109/21681805.2015.1059882
Sobin LH, Wittekind C (eds) (2002) TNM classification of malignant tumours, 6th edn. Wiley-Liss, New York
Elbe JN, Sauter G, Epstein JI, Sesterhenn IA (eds) (2004) Pathology and genetics of tumours of the urinary system and male genital organs (IARC WHO classification of tumours). IARC Press, Lyon
Fuhrman SA, Lasky LC, Limas C (1982) Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 6(7):655–663
Kane CJ, Mallin K, Ritchey J, Cooperberg MR, Carroll PR (2008) Renal cell cancer stage migration: analysis of the National Cancer Data Base. Cancer 113(1):78–83. doi: 10.1002/cncr.23518
Leibovich BC, Blute ML, Cheville JC, Lohse CM, Frank I, Kwon ED, Weaver AL, Parker AS, Zincke H (2003) Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials. Cancer 97(7):1663–1671. doi: 10.1002/cncr.11234
Eggener SE, Yossepowitch O, Pettus JA, Snyder ME, Motzer RJ, Russo P (2006) Renal cell carcinoma recurrence after nephrectomy for localized disease: predicting survival from time of recurrence. J Clin Oncol 24(19):3101–3106. doi: 10.1200/JCO.2005.04.8280
O’Malley RL, Hayn MH, Brewer KA, Underwood W 3rd, Hellenthal NJ, Kim HL, Sorokin I, Schwaab T (2015) Cancer control of partial nephrectomy for high-risk localized renal cell carcinoma: population-based and single-institutional analysis. World J Urol. doi: 10.1007/s00345-015-1538-z
Andersson M, Hashimi F, Lyrdal D, Lundstam S, Hellstrom M (2015) Improved outcome with combined US/CT guidance as compared to US guidance in percutaneous radiofrequency ablation of small renal masses. Acta Radiol 56(12):1519–1526. doi: 10.1177/0284185114558974
Alt AL, Boorjian SA, Lohse CM, Costello BA, Leibovich BC, Blute ML (2011) Survival after complete surgical resection of multiple metastases from renal cell carcinoma. Cancer 117(13):2873–2882. doi: 10.1002/cncr.25836
Kim DY, Karam JA, Wood CG (2014) Role of metastasectomy for metastatic renal cell carcinoma in the era of targeted therapy. World J Urol 32(3):631–642. doi: 10.1007/s00345-014-1293-6